small molecule

DELATESTRYL

TESTOSTERONE ENANTHATE

Loss of exclusivity—loss of exclusivity

CompanyEndo Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand name	DELATESTRYL
Active ingredient	TESTOSTERONE ENANTHATE
Strength	200MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.